OPKO Health (OPK) Tops Q4 EPS by 3c, provides guidance

OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $148.5 million versus the consensus estimate of $139.76 million.

GUIDANCE:

OPKO Health sees Q1 2026 revenue of $125-140 million, versus the consensus of $130.8 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Full Circle Lithium closes $5.14M private placement